FFS
GILD icon

Founders Financial Securities’s Gilead Sciences GILD Stock Holding History

Founders Financial Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
8,321
+51
+0.6% +$6.72K 0.05% 295
2026
Q1 		$1.18M Sell
8,270
-34
-0.4% -$4.76K 0.07% 262
2025
Q4 		$1.02M Buy
8,304
+325
+4% +$39.5K 0.06% 276
2025
Q3 		$886K Buy
7,979
+3,227
+68% +$367K 0.06% 265
2025
Q2 		$527K Buy
4,752
+1,848
+64% +$197K 0.04% 336
2025
Q1 		$309K Sell
2,904
-7,101
-71% -$733K 0.03% 391
2024
Q4 		$924K Sell
10,005
-2,279
-19% -$205K 0.08% 190
2024
Q3 		$1.03M Buy
12,284
+39
+0.3% +$2.98K 0.1% 182
2024
Q2 		$840K Buy
12,245
+413
+3% +$27.6K 0.08% 204
2024
Q1 		$867K Buy
11,832
+833
+8% +$64.1K 0.09% 184
2023
Q4 		$891K Buy
10,999
+1,668
+18% +$130K 0.1% 179
2023
Q3 		$699K Buy
+9,331
New +$718K 0.09% 172
2023
Q2 		– Sell
-2,588
Closed -$215K – 328
2023
Q1 		$215K Buy
2,588
+84
+3% +$6.96K 0.03% 295
2022
Q4 		$215K Buy
+2,504
New +$198K 0.03% 297
2017
Q3 		– Sell
-13,652
Closed -$966K – 95
2017
Q2 		$966K Sell
13,652
-91
-0.7% -$6.05K 0.37% 39
2017
Q1 		$933K Buy
13,743
+3,099
+29% +$218K 0.35% 47
2016
Q4 		$762K Sell
10,644
-35
-0.3% -$2.6K 0.32% 38
2016
Q3 		$845K Buy
+10,679
New +$867K 0.36% 41

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Founders Financial Securities's GILD Position: Q2 2026 in Review

Founders Financial Securities increased its Gilead Sciences (GILD) stake by 0.62% in Q2 2026, buying an estimated $6.72K and bringing the position to 8,321 shares worth $1.05M. The position accounts for 0.05% of the portfolio, ranked #295.

Founders Financial Securities first reported a position in GILD in Q3 2016 and has held it in 18 quarters since. The position peaked at $1.18M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Founders Financial Securities held 8,321 shares of Gilead Sciences worth $1.05M as of Q2 2026.
  • Founders Financial Securities bought 51 Gilead Sciences shares in Q2 2026, an estimated $6.72K.
  • Gilead Sciences made up 0.05% of Founders Financial Securities's portfolio in Q2 2026, its #295 holding.
  • Founders Financial Securities first reported a position in Gilead Sciences in Q3 2016 and has held it in 18 quarters since.
  • Founders Financial Securities's Gilead Sciences position peaked at $1.18M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.